Takeaways From TransATAC Trial on Comparing Prognostic Signatures

December 10, 2016
William J. Gradishar, MD

William J. Gradishar, MD, deputy director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University Feinberg School of Medicine, discusses the takeaways from the TransATAC trial, which was a comprehensive comparison of prognostic signatures in breast cancer.